Back

Prediction of mortality and heart failure admission with the mitraScore after percutaneous mitral valve repair: an external validation study

11 December 2024 (00:00 - 16:00)
Organised by: Logo
Congress Presentation Part of: What's new in valvular heart disease Valvular Heart Disease EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Mr Lucas Javier Barreiro Mesa

Reina Sofia University Hospital, Cordoba (Spain)

3 More presentations in this session

Presentation thumbnail
Frequency, course and prognostic yield of valvular heart disease in the general population- Results from the STAAB cohort study
Doctor M. Chen (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Left ventricular pressure-strain-volume-loop and myocardial work patterns in asymptomatic severe aortic regurgitation with early disease decompensation
Doctor E. de Oliveira (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Prognostic role of right atrial strain in patients with secondary tricuspid regurgitation: insights from the CARE-TR registry
Doctor L. Lupi (Brescia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
What's new in valvular heart disease
Video

The Event

Event poster

EuroEcho-Imaging 2024

11 December - 13 December 2024
You may be interested in
thumbnail
Congress Presentation
Prognostic role of the COAPT risk score in patients with secondary mitral regurgitation (SMR) undergoing M-TEER: Results of a real world registry
thumbnail
Congress Presentation
Post-procedural mitral regurgitation as an independent predictor of morbidity and mortality outcomes
thumbnail
Congress Presentation
Comorbidities and excess mortality of patients with moderate mitral regurgitation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources